ADDITIONAL COVID VACCINE APPOINTMENTS ARE PRESENTLY ON HOLD UNTIL MORE VACCINE IS AVAILABLE
We will update when we receive confirmation of more vaccine
- Please be aware you are able to book appointments quickly and easily by visiting our online booking portal.
- Please note that you will be screened at the time of visit to ensure eligibility
- If you are unable to book an appointment online you may call 1-807-500-1575 to leave a voicemail to request an appointment. Please do not call the pharmacy locations for an appointment, you will be directed to the online booking portal. Voicemails are returned as able, so it is strongly advised to attempt to book online whenever possible.
- Although we will attempt to accommodate requests for either specific vaccine based on your previous dose, in the event that one product is unavailable you will be offered the available option at time of check in. Please note that due to vaccine use during the clinic, we will generally be unable to advise of specific product availability prior to your visit.
- All individuals aged 12+ may receive a first vaccination
- If it has been more than 28 days from your initial dose, you are eligible for a second dose
- If you require vaccination in the home please contact the Thunder Bay District Health Unit; Janzen's Pharmacy does not provide in-home COVID vaccinations.
Booster Dose Eligibility:
- Individuals aged 18+ who have had their second dose at least 84 days prior
- Health care workers and designated essential caregivers in congregate settings.
- Individuals who received 2 doses of the AstraZeneca Vaxzevria vaccine or 1 dose of the Janssen vaccine.
- Indigenous adults and their non-Indigenous household members.
Booster Dose Aged 12-17:
- Individuals aged 12-17 can receive their booster dose in line with the provincial guidelines
Current Fourth Dose Eligibility:
- General Public 60+ or Indigenous or household members 18+ at a minimum interval of 84 days and a recommended interval of 140 days
- Individuals receiving active treatment* (e.g. chemotherapy, targeted therapies, immunotherapy) for solid tumour or hematologic malignancies.
- Recipients of solid-organ transplant and taking immunosuppressive therapy.
- Recipients of chimeric antigen receptor (CAR)-T-cell therapy or hematopoietic stem cell transplant (within 2 years of transplantation or taking immunosuppression therapy).
- Individuals with moderate to severe primary immunodeficiency (e.g. DiGeorge syndrome, Wiskott-Aldrich syndrome).
- Individuals with stage 3 or advanced untreated HIV infection and those with acquired immunodeficiency syndrome.
- Individuals receiving active treatment with the following categories of immunosuppressive therapies: anti-B cell therapies** (monoclonal antibodies targeting CD19, CD20 and CD22), high-dose systemic corticosteroids (refer to the CIG for suggested definition of high dose steroids), alkylating agents, antimetabolites, or tumor-necrosis factor (TNF) inhibitors and other biologic agents that are significantly immunosuppressive.
- Residents of Long-Term Care Homes (LTCH), Retirement Homes (RH), Elder Care Lodges, and elderly living in other congregate settings (e.g. assisted-living facilities, chronic care hospitals, naturally occurring congregate retirement settings/congregate senior’s apartment buildings, etc.).
- If you would like to determine if you qualify for a fourth dose please call the Ministry of Health and Long Term Care information line at 1-888-999-6488 or click here
The Provincial Vaccine Information Line is available to answer questions about the COVID-19 vaccine. Call 1-888-999-6488.